Two projects have produced elastic, ultra-light carbon foams without using a template.
colleagues have made similar, but slightly heavier aerogels, from graphene oxide sheets. Their aerogel is extremely elastic, bouncing back when compressed, so may be useful in absorbing energy and dampening vibrations for a variety of machinery. Although similarly light carbon aerogels have been made before, they have relied on template scaffolds that were later etched away, a technique that limits the size of the final structure. Teams led by Haruhisa Inoue of Kyoto University, and Nobuhisa Iwata of Nagasaki University, both in Japan, generated induced pluripotent stem (iPS) cells from patients with inherited and non-inherited forms of the disease. Neurons derived from these cells were treated with the omega-3 fatty acid docosahexaenoic acid -which has previously failed in some clinical trials for Alzheimer's
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Carbon cycles Down Under
Despite emissions from wildfires, changes in land use and extreme variability in carbon uptake from the biosphere, Australian
METABOLISM
Insulin's daily rhythm
The increased risk of type 2 diabetes and obesity seen in people who keep unusual hours may be tied to daily, or circadian, rhythms relating to the blood-glucose-regulating hormone insulin.
Carl Hirschie Johnson and his group at Vanderbilt University in Nashville, Tennessee, showed that mice are less responsive to insulin during the day -when they rest. The researchers disrupted the day-night cycles of mice by exposing them to continuous light or by knocking out a gene that is associated with the circadian clock. When fed a high-fat diet, the disrupted mice became fatter than nondisrupted animals.
The authors suggest that the human internal clock could be targeted to modify metabolic diseases. disease. The compound partially increased the survival time of neurons from a patient with an inherited form of the disease but had no effect on the survival of neurons from patients with non-inherited disease. Responses to cellular stress as well as accumulation of the protein amyloid-β, which is associated with the disease, also varied between neurons derived from different patients.
The authors suggest that patient-specific iPS cells could help researchers to explain variable clinical results and guide drug development. 
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